Coronavirus Clinical Trials
Here are the 6 most popular medical studies for coronavirus
mRNA Vaccine
mRNA COVID-19 Vaccines Safety for Previous Vaccine Reactions
This trial is being conducted to see if people who have had bad reactions to COVID-19 vaccines in the past can safely have another dose, or if people with a history of allergies can safely have the vaccine at all.
Behavioral Intervention
Stepped Alcohol Intervention for Alcohol-related Liver Disease
This trial is testing a new way to help people with chronic liver disease who have unhealthy alcohol use. The new treatment includes 3 sessions of motivational interviewing, and referral to addiction medicine if necessary. The trial will measure how well the new treatment works at 6 and 12 months.
Behavioral Intervention
Physical activity +1 More for Coronavirus
This trial aims to find efficient treatments to help those with chemosensory losses due to Coronavirus disease (COVID-19). 75 participants will be recruited and randomly assigned to one of three groups: physical activity, smell training, or control. The groups will engage in their assigned activities for 12 weeks and be assessed at the beginning, end, and 12 weeks after the end of the intervention period.
Popular filter options for coronavirus trials
COVID-19 Clinical Trials
View 96 COVID-19 medical studies.
Vitamin Supplement
Vitamin D for COVID-19
This trial is testing whether vitamin D supplements can reduce the rate of people seeking healthcare for symptoms related to COVID-19, and whether it can reduce the risk of infection with the virus in people who have been recently diagnosed with COVID-19.
Anti-metabolites
Decitabine for COVID-19
This trial is testing if the leukemia drug decitabine can help people with severe COVID-19. 40 people will be enrolled, half receiving decitabine and half receiving a placebo. The primary objective is to determine if decitabine is safe and effective for COVID-19 ARDS.
Acute Respiratory Distress Syndrome Clinical Trials
View 7 Acute Respiratory Distress Syndrome medical studies.
Monoclonal Antibodies
EB05 for Hospitalized COVID-19 Patients
This trial is testing a potential new treatment, EB05, for people who have been hospitalized with COVID-19. The treatment is designed to target the initial step in the signalling pathways of these DAMPs in innate immunity.
Pneumatic Device
V/Q System for Acute Respiratory Distress Syndrome in COVID-19
This trial is looking at whether a vest that inflates and deflates around the chest can help improve oxygenation for people with ARDS who have COVID-19 and are on mechanical ventilation.
Phase 3 Coronavirus Clinical Trials
View 99 phase 3 coronavirus medical studies.
Vitamin Supplement
Vitamin D for COVID-19
This trial is testing whether vitamin D supplements can reduce the rate of people seeking healthcare for symptoms related to COVID-19, and whether it can reduce the risk of infection with the virus in people who have been recently diagnosed with COVID-19.
Immunoglobulin
hIVIG for COVID-19
This trial is for people with recently diagnosed SARS-CoV-2 infection who do not require hospitalization. The goal is to compare the safety and efficacy of a single infusion of anti-COVID-19 hyperimmune intravenous immunoglobulin (hIVIG) versus placebo.
Coronavirus Clinical Trials With No Placebo
View 99 coronavirus medical studies that do not have a placebo group.
Virus Therapy
Trivalent Coronavirus Vaccine VBI-2901a for COVID-19
This trial is testing a vaccine candidate that uses particles to express the spike proteins of three coronaviruses: SARS-CoV-2, SARS-CoV-1, and MERS-CoV. The Phase 1 study will compare the safety of two doses of the vaccine candidate in adults 18-64 years old who have previously received two or more vaccinations for COVID-19. The purpose of the study is to test the safety of the vaccine candidate and to learn more about its ability to boost immunity against SARS-CoV-2 and the other two coronaviruses.
Behavioural Intervention
Psychological Well-being Intervention for Healthcare Worker Burnout During COVID-19
This trial will assess the effectiveness of an online psychological well-being intervention (PARK) in reducing stress and associated-burnout, absenteeism, and intentions to leave the workforce in a subset of 750 persons who have been participating in a study of healthcare workers at Northwestern Medicine (NM) since Spring 2020.
View More Coronavirus Trials
See another 69 medical studies focused on coronavirus.
Frequently Asked Questions
Introduction to coronavirus
What are the top hospitals conducting coronavirus research?
As the world continues to grapple with the ongoing COVID-19 pandemic, hospitals are playing a crucial role in conducting clinical trials to find effective treatments and vaccines. Among these institutions is the University of Michigan in Ann Arbor, which has embarked on two active coronavirus trials, marking an important step forward in combating this global crisis. Having recorded its first trial in 2020, the university is dedicated to exploring innovative approaches to tackle the virus head-on. Meanwhile, Grady Health System in Atlanta has one ongoing coronavirus trial underway. While they may not have conducted any previous trials specifically focused on COVID-19, their involvement signifies their commitment to contribute towards finding solutions for this unprecedented health challenge.
In Atlanta itself, other hospitals are also actively engaged in advancing our understanding of and response to COVID-19. Emory University Hospital Midtown has initiated one current coronavirus trial along with having accomplished a single prior investigation since recording its inaugural coronavirus trial in 2020. Similarly, Emory Hospital and Metro-Atlanta each have one active coronavirus trial but do not possess any completed trials at present.
These hospitals’ dedication demonstrates their pivotal roles as centers of research and innovation during these challenging times. Through rigorous scientific exploration and collaboration among medical professionals across diverse locations like Ann Arbor and Atlanta alike, progress is made toward identifying strategies that will ultimately help us overcome this devastating global pandemic together
Which are the best cities for coronavirus clinical trials?
When it comes to coronavirus clinical trials, several cities emerge as leaders in research and development. Atlanta, Georgia, Houston, Texas, Toronto, Ontario, New york City, and Washington D.C. are among the top locations with active trials. These cities offer individuals access to studies focusing on various treatments such as LDN Treatment Arm and 9vHPV Vaccine in Atlanta; Niclosamide and 700mg Leronlimab in Houston; VBI-2901a and Aspirin Treatment in Toronto; Hyperimmune immunoglobulin to SARS-CoV-2 (hIVIG) and Stress First Aid in New York City; Hyperimmune immunoglobulin to SARS-CoV-2 (hIVIG)and 9vHPV Vaccine in Washington D.C. By conducting these trials across different regions, researchers aim to advance our understanding of potential treatment options for COVID-19.
Which are the top treatments for coronavirus being explored in clinical trials?
The race to find effective treatments for the coronavirus continues, with several promising options emerging in clinical trials. Leading the pack is VBI-2901a, currently being tested in one active trial dedicated to fighting this global pandemic. Another contender gaining attention is the 9vHPV vaccine, also undergoing evaluation in one ongoing coronavirus trial. Baricitinib completes the lineup as a potential treatment option, with two all-time trials and one active trial focused on combatting COVID-19 since its first listing in 2020. These innovative therapies offer hope for a brighter future amidst these challenging times.
What are the most recent clinical trials for coronavirus?
Recent clinical trials for coronavirus offer promising prospects in the fight against this global pandemic. These include innovative approaches such as intravenously delivered MSC-exosomes, which are administered every other day on an escalating dose to combat the virus. Additionally, the mRNA-CR-04 vaccine has shown potential in early-phase trials, providing hope for effective immunization strategies. Another trial examines azeliragon's efficacy as a treatment option through its progression from Phase 2 to Phase 3 studies. Furthermore, the mRNA-1045 Dose Level B and VBI-2901a have both entered Phase 1 trials, demonstrating ongoing efforts to discover new therapeutic interventions against coronavirus infection. These cutting-edge clinical investigations signify significant advancements in our collective battle against COVID-19.
What coronavirus clinical trials were recently completed?
Several significant clinical trials for coronavirus have recently reached completion, showcasing the relentless efforts to combat this global health crisis. Notably, in August 2021, Merck Sharp & Dohme Corp. concluded a trial investigating the potential of Molnupiravir as a treatment option. Around the same time, Janssen Vaccines & Prevention B.V.'s trial on Ad26.COV2.S came to an end, examining its efficacy as a vaccine candidate. Additionally, research led by James L. Kirkland explored Fisetin's potential against COVID-19 and was completed in July 2021. These trials represent critical steps forward in our ongoing battle against the pandemic and demonstrate the dedication of researchers worldwide towards finding effective solutions.